U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec 527.400 Whole Milk, Lowfat Milk, Skim Milk - Aflatoxin M1
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec 527.400 Whole Milk, Lowfat Milk, Skim Milk - Aflatoxin M1 November 2005

Final
Issued by:
Guidance Issuing Office
Office of Regulatory Affairs
Center for Food Safety and Applied Nutrition

BACKGROUND:

Aflatoxins are a group of chemically related toxins produced as natural by-products during the growth of certain common molds. The aflatoxins are designated as B1, B2, G1, and G2. These compounds are demonstrated liver toxins and liver carcinogens. Aflatoxin B1 is considered the most potent of this group. They are potential contaminants of several commodities including corn. If a particular corn crop is stressed, for example, by drought or insect attack it is susceptible to mold growth and aflatoxin contamination.

A metabolite of aflatoxin B1 that is produced during normal biological processes of animals ingesting the toxin is chemically similar to B1 and has been designated as aflatoxin M1. The aflatoxin M1, though less potent than B1, has been shown to cause liver cancer in certain animals. Because the M1 metabolite may occur in the milk of dairy cattle ingesting feed contaminated with aflatoxin B1, exposure of these animals to aflatoxin contaminated feed should be minimized.

As a result of adverse weather conditions, insect damage and possibly other undetermined factors, the 1977 corn crop grown in the southeastern United States was severely affected by growth of aflatoxin producing molds. The Agency conducted surveys in the southeastern states to determine the incidence of aflatoxin M1 contamination of fluid milk products. The results of these surveys showed that aflatoxin contamination of milk in at least four southeastern states was a potentially serious public health hazard. The Commissioner therefore established a 0.5 parts per billion (ppb) action guideline for aflatoxin contamination of fluid milk products in 1977.

The Agency routinely monitors milk and milk products for aflatoxin contamination. It has generally been observed that the incidence and levels of aflatoxin M1 contamination varies with the extent of aflatoxin contamination of the corn crop for a particular year.

REGULATORY ACTION GUIDANCE:

The following represents criteria that should be considered when deciding whether to recommend legal action to CFSAN/Office of *Compliance*/Division of Enforcement (HFS-605):

The original and check analysis show that the sample contains greater than 0.5 ppb aflatoxin M1 and the identity of aflatoxin M1 is confirmed by the chemical derivative test.

METHODOLOGY:

Samples of fluid milk products collected for aflatoxin M1 analysis shall consist of not less than 10 pounds composited from not less than 10 units or portions of units randomly selected from a given lot. In the case of bulk units, the composite 10 pound sample may be drawn directly from bulk fluid storage after adequate mixing of the contents and flushing of the sampling valve.

Prior to analysis, the total sample shall be mixed in a manner to provide analytical samples that are representative of the composite. Duplicate aliquots of the well mixed sample shall be analyzed by one of the methods for aflatoxin M1 in dairy products described in AOAC Official Methods of Analysis (1990) 15th edition, sections 974.17, 980.21 and 986.16. Confirmation of the aflatoxin identity shall be by the method described in section 980.21.

*Material between asterisks is new or revised.*

Issued: 10/1/80
Revised: 3/95, 8/96, 5/05
Updated: 11/29/05


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

Back to Top